PortalPublikationenPrevention and treatment of relapse after stem cell transpla...

Prevention and treatment of relapse after stem cell transplantation with immunotherapy

Standard

Prevention and treatment of relapse after stem cell transplantation with immunotherapy. / Gökbuget, Nicola; Canaani, Jonathan; Nagler, Arnon; Bishop, Michael; Kröger, Nicolaus; Avigan, David.

in: BONE MARROW TRANSPL, Jahrgang 53, Nr. 6, 06.2018, S. 664-672.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Gökbuget, N, Canaani, J, Nagler, A, Bishop, M, Kröger, N & Avigan, D 2018, 'Prevention and treatment of relapse after stem cell transplantation with immunotherapy', BONE MARROW TRANSPL, Jg. 53, Nr. 6, S. 664-672. https://doi.org/10.1038/s41409-018-0232-3

APA

Gökbuget, N., Canaani, J., Nagler, A., Bishop, M., Kröger, N., & Avigan, D. (2018). Prevention and treatment of relapse after stem cell transplantation with immunotherapy. BONE MARROW TRANSPL, 53(6), 664-672. https://doi.org/10.1038/s41409-018-0232-3

Vancouver

Gökbuget N, Canaani J, Nagler A, Bishop M, Kröger N, Avigan D. Prevention and treatment of relapse after stem cell transplantation with immunotherapy. BONE MARROW TRANSPL. 2018 Jun;53(6):664-672. https://doi.org/10.1038/s41409-018-0232-3

Bibtex

@article{31700632ac8c4c12ba340eb60913aacc,
title = "Prevention and treatment of relapse after stem cell transplantation with immunotherapy",
abstract = "Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.",
keywords = "Journal Article, Review",
author = "Nicola G{\"o}kbuget and Jonathan Canaani and Arnon Nagler and Michael Bishop and Nicolaus Kr{\"o}ger and David Avigan",
year = "2018",
month = jun,
doi = "10.1038/s41409-018-0232-3",
language = "English",
volume = "53",
pages = "664--672",
journal = "BONE MARROW TRANSPL",
issn = "0268-3369",
publisher = "NATURE PUBLISHING GROUP",
number = "6",

}

RIS

TY - JOUR

T1 - Prevention and treatment of relapse after stem cell transplantation with immunotherapy

AU - Gökbuget, Nicola

AU - Canaani, Jonathan

AU - Nagler, Arnon

AU - Bishop, Michael

AU - Kröger, Nicolaus

AU - Avigan, David

PY - 2018/6

Y1 - 2018/6

N2 - Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.

AB - Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.

KW - Journal Article

KW - Review

U2 - 10.1038/s41409-018-0232-3

DO - 10.1038/s41409-018-0232-3

M3 - SCORING: Review article

C2 - 29795427

VL - 53

SP - 664

EP - 672

JO - BONE MARROW TRANSPL

JF - BONE MARROW TRANSPL

SN - 0268-3369

IS - 6

ER -